213 related articles for article (PubMed ID: 31796215)
1. Synthesis and discovery of pyrazolo-pyridine analogs as inflammation medications through pro- and anti-inflammatory cytokine and COX-2 inhibition assessments.
Dennis Bilavendran J; Manikandan A; Thangarasu P; Sivakumar K
Bioorg Chem; 2020 Jan; 94():103484. PubMed ID: 31796215
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of new pyrazoles and pyrozolo [3,4-b] pyridines as anti-inflammatory agents by inhibition of COX-2 enzyme.
Mohamed LW; Shaaban MA; Zaher AF; Alhamaky SM; Elsahar AM
Bioorg Chem; 2019 Mar; 83():47-54. PubMed ID: 30342385
[TBL] [Abstract][Full Text] [Related]
3. New methyl 5-(halomethyl)-1-aryl-1H-1,2,4-triazole-3-carboxylates as selective COX-2 inhibitors and anti-inflammatory agents: Design, synthesis, biological evaluation, and docking study.
Li SM; Tsai SE; Chiang CY; Chung CY; Chuang TJ; Tseng CC; Jiang WP; Huang GJ; Lin CY; Yang YC; Fuh MT; Wong FF
Bioorg Chem; 2020 Nov; 104():104333. PubMed ID: 33142408
[TBL] [Abstract][Full Text] [Related]
4. Optimization of pyrazole-based compounds with 1,2,4-triazole-3-thiol moiety as selective COX-2 inhibitors cardioprotective drug candidates: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory, ulcerogenicity, cardiovascular evaluation, and molecular modeling studies.
Abdellatif KRA; Abdelall EKA; Elshemy HAH; Philoppes JN; Hassanein EHM; Kahk NM
Bioorg Chem; 2021 Sep; 114():105122. PubMed ID: 34243075
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, anti-inflammatory activity, and molecular docking studies of perimidine derivatives containing triazole.
Zhang HJ; Wang XZ; Cao Q; Gong GH; Quan ZS
Bioorg Med Chem Lett; 2017 Sep; 27(18):4409-4414. PubMed ID: 28823493
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and docking analysis of 3-methyl-1-phenylchromeno[4,3-c]pyrazol-4(1H)-ones as potential cyclooxygenase-2 (COX-2) inhibitors.
Grover J; Kumar V; Sobhia ME; Jachak SM
Bioorg Med Chem Lett; 2014 Oct; 24(19):4638-4642. PubMed ID: 25219899
[TBL] [Abstract][Full Text] [Related]
7. Discovery, synthesis and molecular corroborations of medicinally important novel pyrazoles; drug efficacy determinations through in silico, in vitro and cytotoxicity validations.
Thangarasu P; Manikandan A; Thamaraiselvi S
Bioorg Chem; 2019 May; 86():410-419. PubMed ID: 30769266
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,5-diarylpyrazole derivatives.
Abdellatif KR; Fadaly WA; Ali WA; Kamel GM
J Enzyme Inhib Med Chem; 2016; 31(sup3):54-60. PubMed ID: 27541738
[TBL] [Abstract][Full Text] [Related]
9. Stomopneulactone D from long-spined sea urchin Stomopneustes variolaris: Anti-inflammatory macrocylic lactone attenuates cyclooxygenase-2 expression in lipopolysaccharide-activated macrophages.
Chakraborty K; Francis P
Bioorg Chem; 2020 Oct; 103():104140. PubMed ID: 32763520
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 and 15-lipoxygenase inhibition, synthesis, anti-inflammatory activity and ulcer liability of new celecoxib analogues: Determination of region-specific pyrazole ring formation by NOESY.
Abdelall EKA; Lamie PF; Ali WAM
Bioorg Med Chem Lett; 2016 Jun; 26(12):2893-2899. PubMed ID: 27158139
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory drug approach: Synthesis and biological evaluation of novel pyrazolo[3,4-d]pyrimidine compounds.
Atatreh N; Youssef AM; Ghattas MA; Al Sorkhy M; Alrawashdeh S; Al-Harbi KB; El-Ashmawy IM; Almundarij TI; Abdelghani AA; Abd-El-Aziz AS
Bioorg Chem; 2019 May; 86():393-400. PubMed ID: 30763886
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: design, synthesis, and structure-activity relationship.
Hayashi S; Sumi Y; Ueno N; Murase A; Takada J
Biochem Pharmacol; 2011 Oct; 82(7):755-68. PubMed ID: 21741371
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, evaluation and docking of novel pyrazolo pyrimidines as potent p38α MAP kinase inhibitors with improved anti-inflammatory, ulcerogenic and TNF-α inhibitory properties.
Somakala K; Tariq S; Amir M
Bioorg Chem; 2019 Jun; 87():550-559. PubMed ID: 30928877
[TBL] [Abstract][Full Text] [Related]
14. Ligand based design and synthesis of pyrazole based derivatives as selective COX-2 inhibitors.
Murahari M; Mahajan V; Neeladri S; Kumar MS; Mayur YC
Bioorg Chem; 2019 May; 86():583-597. PubMed ID: 30782576
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel halogenated triarylpyrazoles as selective COX-2 inhibitors: Anti-inflammatory activity, histopatholgical profile and in-silico studies.
Abdellatif KRA; Abdelall EKA; Labib MB; Fadaly WAA; Zidan TH
Bioorg Chem; 2020 Dec; 105():104418. PubMed ID: 33166844
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and mechanistic study of novel diarylpyrazole derivatives as anti-inflammatory agents with reduced cardiovascular side effects.
Amin NH; Hamed MIA; Abdel-Fattah MM; Abusabaa AHA; El-Saadi MT
Bioorg Chem; 2021 Nov; 116():105394. PubMed ID: 34619468
[TBL] [Abstract][Full Text] [Related]
17. Non-acidic 1,3,4-trisubstituted-pyrazole derivatives as lonazolac analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
Abdellatif KRA; Fadaly WAA; Elshaier YAMM; Ali WAM; Kamel GM
Bioorg Chem; 2018 Apr; 77():568-578. PubMed ID: 29475165
[TBL] [Abstract][Full Text] [Related]
18. Dual COX-2 and 15-LOX inhibition study of novel 4-arylidine-2-mercapto-1-phenyl-1H-imidazolidin-5(4H)-ones: Design, synthesis, docking, and anti-inflammatory activity.
Osman NA; Soltan MK; Rezq S; Flaherty J; Romero DG; Abdelkhalek AS
Arch Pharm (Weinheim); 2024 May; 357(5):e2300615. PubMed ID: 38315093
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, in vitro and in vivo biological evaluation, COX-1/2 inhibition and molecular docking study of indole-N-acylhydrazone derivatives.
Moraes ADTO; Miranda MDS; Jacob ÍTT; Amorim CADC; Moura RO; Silva SÂSD; Soares MBP; Almeida SMV; Souza TRCL; Oliveira JF; Silva TGD; Melo CML; Moreira DRM; Lima MDCA
Bioorg Med Chem; 2018 Nov; 26(20):5388-5396. PubMed ID: 30293795
[TBL] [Abstract][Full Text] [Related]
20. Molecular docking design and one-pot expeditious synthesis of novel 2,5-diarylpyrazolo[1,5-a]pyrimidin-7-amines as anti-inflammatory agents.
Aggarwal R; Singh G; Kaushik P; Kaushik D; Paliwal D; Kumar A
Eur J Med Chem; 2015 Aug; 101():326-33. PubMed ID: 26160113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
